Bundled skin antiseptic preparation for complex cardiac implantable electronic device infection – a propensity score matching cohort study
ConclusionsBundled skin antiseptic preparation is an effective and widely applicable strategy for decreasing infection risk after a complex CIED implantation.
This article includes also recently announced findings on the TRANSITION study which revealed that HFrEF therapy with ARNI might be safely initiated after an acute decompensated heart failure episode, including patients with heart failure de novo and ACEI/ARB na ïve, both hospitalised or shortly after discharge, in contrary to the PARADIGM-HF trial, where patients had to be administered a stable dose of an ACEI/ARB equivalent to enalapril 10 mg a day for at least 4 weeks before the screening.
ConclusionsOur study suggests that RV free wall pacing may be a significant risk factor for LV dysfunction. Pacemaker-induced LV dysfunction was improved via lead relocation to the RV apex or cardiac resynchronization therapy upgrade. Future studies with a bigger sample size and longer-term follow-up are required to confirm our results.
AbstractBackgroundLittle data is available about radiation exposure during cardiac electrical device implantation, and no dose reference levels have been published. This multicenter, prospective, observational study assesses patient and staff radiation exposure during cardiac device implantations, and aims at defining dose reference levels.MethodsPatient demographic, procedural and radiation data were obtained for 657 procedures from nine institutions. Physician and staff exposure were measured using real ‐time dosimeters worn beneath and above lead apron. Statistical analysis included fluoroscopy time, dose‐area produ...
Condition: Cardiac Resynchronisation Therapy Intervention: Device: Implant test procedure Sponsors: University Hospital, Rouen; MicroPort CRM Not yet recruiting
Condition: LVAD (Left Ventricular Assist Device) Driveline Infection Intervention: Other: Temporary changes in an already-implanted medical device (biventricular pacemaker) Sponsors: University of California, Davis; University of California, San Diego Active, not recruiting
Abstract BACKGROUND: The first European Cardiac Resynchronization Therapy (CRT) Survey, conducted in 2008-2009, showed considerable variations in guideline adherence and implantation practice. A second prospective survey (CRT Survey II) was then performed to describe contemporary clinical practice regarding CRT among 42 European countries. AIM: To compare the characteristics of French CRT recipients with the overall European population of CRT Survey II. METHODS: Demographic and procedural data from French centres recruiting all consecutive patients undergoing either de novo CRT implantation or an upgrade...
This study included 36 patients. At rest, AV intervals changed minimally with posture. With atrial pacing, AV interval immediately increased compared with sinus rhythm, with ARV slopes being 8.1 ±7.7, 8.8±13.4 and 6.8±6.5 milliseconds per beat per minute (ms/bpm) and ALV slopes being 8.2±7.7, 9.1±12.8, and 7.0±6.5 ms/bpm for supine, standing and sitting positions, respectively. As paced heart rate increased, ARV and ALV intervals increased more gradually with similar trends. Intervent ricular conduction times changed
ConclusionsSurvival after appropriate tachyarrhythmia therapies, particularly shocks, is attenuated in patients with GFR ≤30. This raises concern over potential lack of survival benefit conferred by CRT‐defibrillators versus CRT‐pacemakers in this population.This article is protected by copyright. All rights reserved
ABSTRACTBackgroundMultiPoint Pacing (MPP) may improve clinical outcomes in patients with cardiac resynchronization therapy defibrillators (CRT ‐D), but its impact on battery longevity in a real‐world population has not been investigated in large trials.ObjectiveCompare projected battery longevity in CRT ‐D patients with and without MPP during long‐term follow‐up.MethodsThe Italian Registry On Multipoint Left Ventricular Pacing (IRON ‐MPP) is a prospective, multicenter registry of patients implanted with MPP‐capable CRT‐D devices. Projected battery longevity during follow‐up was compared for patients with ...